This result is consistent with several earlier findings that GRM4 expressed in human OS cells is associated with its proper function and its expression in pediatric CNS tumors, rhabdomyosarcoma, multiple myeloma and colorectal cancer is predicted with poor prognosis [35, 46–49]. Here, GRM4 is linked to plasma cell myeloma.